Evidence map›Paper›PMID 19909758›Full record

ReviewMutation research2010

Uracil-DNA glycosylase: Structural, thermodynamic and kinetic aspects of lesion search and recognition.

Dmitry O Zharkov, Grigory V Mechetin, Georgy A Nevinsky

Open access · greenAbstract readReview
In one paragraph

Review in Mutation research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Article
  3. Usnic Acid Derivatives as Inhibitors ofInternational journal of molecular sciences · 2026
    Article
  4. Base excision repair inFrontiers in microbiology · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Tandem Substitutions in Somatic Hypermutation.Frontiers in immunology · 2021
    Article
  17. How Human H1 Histone Recognizes DNA.Molecules (Basel, Switzerland) · 2020
    Article
  18. Inhibitors of DNA Glycosylases as Prospective Drugs.International journal of molecular sciences · 2020
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Dmitry O ZharkovSB RAS Institute of Chemical Biology and Fundamental Medicine, 8 Lavrentieva Ave., Novosibirsk 630090, Russia. dzharkov@niboch.nsc.ru
Grigory V Mechetin
Georgy A Nevinsky
Institute of Chemical Biology and Fundamental Medicine · RUNovosibirsk State University · RU

Funding

POTENTIAL ANTIVIRAL AGENTS--TRIPHENYLMETHANE DYESR01CA017395 · NCI · STATE UNIVERSITY NEW YORK STONY BROOK · PI GROLLMAN, ARTHUR PATRICK · 1985 to 2012
$4.1M
NCI NIH HHS R01 CA017395
6 · The paper itself

Abstract

Uracil appears in DNA as a result of cytosine deamination and by incorporation from the dUTP pool. As potentially mutagenic and deleterious for cell regulation, uracil must be removed from DNA. The major pathway of its repair is initiated by uracil-DNA glycosylases (UNG), ubiquitously found enzymes that hydrolyze the N-glycosidic bond of deoxyuridine in DNA. This review describes the current understanding of the mechanism of uracil search and recognition by UNG. The structure of UNG proteins from several species has been solved, revealing a specific uracil-binding pocket located in a DNA-binding groove. DNA in the complex with UNG is highly distorted to allow the extrahelical recognition of uracil. Thermodynamic studies suggest that UNG binds with appreciable affinity to any DNA, mainly due to the interactions with the charged backbone. The increase in the affinity for damaged DNA is insufficient to account for the exquisite specificity of UNG for uracil. This specificity is likely to result from multistep lesion recognition process, in which normal bases are rejected at one or several pre-excision stages of enzyme-substrate complex isomerization, and only uracil can proceed to enter the active site in a catalytically competent conformation. Search for the lesion by UNG involves random sliding along DNA alternating with dissociation-association events and partial eversion of undamaged bases for initial sampling.

Indexed as

AnimalsBase SequenceDNA RepairHumansKineticsModels, MolecularMolecular Sequence DataThermodynamicsUracilUracil-DNA GlycosidaseUracilUracil-DNA Glycosidase

Identifiers

PMID19909758
PMCPMC3000906
OpenAlexW2039872984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.